BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37974444)

  • 1. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
    Rane BR; Chavan PY; Kate NS; Jain AS
    Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization,
    Shinde G; Desai P; Shelke S; Patel R; Bangale G; Kulkarni D
    J Dermatolog Treat; 2022 Mar; 33(2):885-896. PubMed ID: 32603203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-by-Design-Assisted Optimization of Carvacrol Oil-Loaded Niosomal Gel for Anti-Inflammatory Efficacy by Topical Route.
    Ghazwani M; Hani U; Alam A; Alqarni MH
    Gels; 2023 May; 9(5):. PubMed ID: 37232993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
    [No Abstract]   [Full Text] [Related]  

  • 7. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonionic surfactant-based vesicular system for transdermal drug delivery.
    Ghanbarzadeh S; Khorrami A; Arami S
    Drug Deliv; 2015 Dec; 22(8):1071-1077. PubMed ID: 24400680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches.
    Waqas MK; Sadia H; Khan MI; Omer MO; Siddique MI; Qamar S; Zaman M; Butt MH; Mustafa MW; Rasool N
    Des Monomers Polym; 2022; 25(1):165-174. PubMed ID: 35711622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
    Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
    J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
    Patel KK; Kumar P; Thakkar HP
    AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
    Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
    Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
    Jain N; Verma A; Jain N
    Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study.
    Zaid Alkilani A; Hamed R; Abdo H; Swellmeen L; Basheer HA; Wahdan W; Abu Kwiak AD
    ACS Omega; 2022 Nov; 7(44):39782-39793. PubMed ID: 36385887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained transdermal delivery of human growth hormone from niosomal gel:
    Wang L; Wei L; Long W; Zhang Q; Zou Y
    J Biomater Sci Polym Ed; 2022 Jun; 33(9):1198-1212. PubMed ID: 35192434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
    Aziz DE; Abdelbary AA; Elassasy AI
    Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation optimization,
    Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
    Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.